A pivotal Supreme Court case could determine whether millions of Americans will lose no-cost access to colorectal cancer (CRC) screening—a move the American College of Gastroenterology (ACG) warns could erase decades of progress in cancer prevention.
In Kennedy v. Braidwood, the court is weighing the constitutionality of the USPSTF’s authority, which currently underpins ACA-mandated coverage for preventive services like CRC screening. If overturned, patients may face out-of-pocket costs—adding yet another barrier to early detection. The ACG responded by filing a forceful amicus brief, warning that reversing these protections could drastically reduce screening rates and lead to preventable deaths.